Cost-effectiveness study comparing imatinib with interferon-alpha for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the Chinese public health-care system perspective (CPHSP). (Q43002147)
Jump to navigation
Jump to search
scientific article published in November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness study comparing imatinib with interferon-alpha for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the Chinese public health-care system perspective (CPHSP). |
scientific article published in November 2009 |
Statements
1 reference
Cost-effectiveness study comparing imatinib with interferon-alpha for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the Chinese public health-care system perspective (CPHSP). (English)
1 reference
Zi Chen
1 reference
Chun Wang
1 reference
Xiaoping Xu
1 reference
Weiwei Feng
1 reference
1 November 2009
1 reference
1 reference
12 Suppl 3
1 reference
S85-8
1 reference
Identifiers
1 reference
1 reference